Pyxis Oncology Receives $8M Payment from Novartis
Wednesday, 27 March 2024, 11:43
Pyxis Oncology Announces Novartis Deal:
Pyxis Oncology has finalized the sale of its royalty rights to Novartis for a substantial $8 million, with the transaction expected to be recorded in Q1 2024.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.